IFN-β and multiple sclerosis: From etiology to therapy and back
Viviana Annibali(Azienda Ospedaliera Sant'Andrea), Giovanni Ristori, Francesco Orzi(Sapienza University of Rome), Vito A. G. Ricigliano(Inserm), Rosella Mechelli, Marco Salvetti(Istituto Neurologico Mediterraneo), Maria Chiara Buscarinu(Sapienza University of Rome), Silvia Romano, Arianna Fornasiero, Renato Umeton(Harvard University), Eliana M. Coccia(Istituto Superiore di Sanità)
Cited by 36
Related Papers
A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
|PLoS ONE|2013|511
Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
|JAMA Oncology|2022|383
The TRIPOD-LLM reporting guideline for studies using large language models
|Nature Medicine|2025|340
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
|Multiple Sclerosis Journal|2015|298